Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells

International Journal of Cancer

Volumn 73, Issue 2, 1997, Pages 277-282

  De Luca, Antonella ^a   Selvam, Mouna P ^b   Sandomemco, Claudia ^c   Pepe, Stefano ^c   Bianco, A Raffaele ^c   Ciardiello, Fortunato ^c   Salomon, David S ^d   Normanno, Nicola ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; CISPLATIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR; FLUOROURACIL; MITOMYCIN C; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; TRANSFORMING GROWTH FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CELL PROLIFERATION; COLON CANCER; COLON CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL DIVISION; CISPLATIN; COLONIC NEOPLASMS; DNA, NEOPLASM; DOXORUBICIN; DRUG COMBINATIONS; DRUG SYNERGISM; EPIDERMAL GROWTH FACTOR; FLOW CYTOMETRY; FLUOROURACIL; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE GLYCOPROTEINS; MITOMYCIN; NEOPLASM PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; THIONUCLEOTIDES; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED;

EID: 0030866189     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971009)73:2<277::AID-IJC19>3.0.CO;2-C     Document Type: Article

References (25)

1. AARONSON, S.A., Growth factors and cancer. Science, 254, 1146-1153 (1491).
2. ARTEAGA, C.L., WINNIER, A.R., POIRIER, M.C., LOPEZ-LARRAZA, D.M., SHAWVER, L.K., HURD, S.D. and STEWART, S.J., p185c-erbB-2 signaling enhances cisplatin-induced cytotoxicity in human breast-carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug- induced DNA repair. Cancer Res., 54, 3758-3765 (1994).
3. BASLELGA, J., NORTON, L., MASUI, H., PANDIELLA, A., COPLAN, K., MILLER, W.H. and MENDELSOHN, J., Anti-tumor effects of doxorubicin in combination with anti-epidermal-growth-factor-receptor monoclonal antibodies. J. nat. Cancer Inst., 85, 1327-1333 (1993).
4. BLAGOSKLONNY, M.V. and NECKERS, L., Oligonucleotides protect cells from the cytotoxicity of several anti-cancer chemotherapeutic drugs. Anti-Cancer Drug. 5, 437-44 (1994).
5. BRANDT, R., NORMANNO, N., GULLICK, W.J., LIN, J.H., HARKINS, R., SCHNEIDER, D., JONES, B.W., CIARDIELLO, F., PERSICO, M.G., ARMENANTE, F., KIM, N. and SALOMON, D.S., Identification and biological characterization of an epidermal-growth-tactor-related protein: cripto-1. J. biol. Chem., 269, 17320-17328 (1994).
6. CHRISTEN, R.D., HOM, D.K., MACLEOD, C.L., HAFSTROM, L. and HOWELL, S.B, Epidermal growth factor regulates the in vitro sensitivity of human ovarian-carcinoma cells to cisplatin. J. Clin. Invest., 86, 1632-1640 (1990).
7. CIARDIELLO, F., BIANCO, C., NORMANNO, N., BALDASSARRE, G., PEPE, S., TORTORA, G., BIANCO, A.R. and SALOMON, D.S., Infection with a transforming-growth-factor-α anti-sense retroviral expression vector reduces the in vitro growth and transformation of a human colon-cancer cell line. Int. J. Cancer. 54, 952-958 (1993).
8. CIARDIELLO, F., DAMIANO, V., BIANCO, C., DI ISERNIA, G., RUGGIERO, A., CARAGLIA, M., TAGLIAFERRI, P., BASELGA, J., MENDELSOHN, J., BIANCO, A.R. and TORTORA, G., Cooperative anti-proliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal-growth-factor-receptor monoclonal antibody on human cancer cells. Clin. Cancer Res., 1, 161-167 (1995).
9. CIARDIELLO, F., KIM, N., SAEKI, T., DONO, R., PERSICO, M.G., PLOWMAN, G.D., GARRIGUES, J., RADKE, S., TODARO, G.J. and SALOMON, D.S., Differential expression of epidermal-growth-factor-related proteins in human colorectal tumors. Proc. nat. Acad. Sci. (Wash.), 88, 7792-7796 (1991).
10. CIARDIELLO, F. TORTORA, G., BIANCO, C., SELVAM, M.P., BASOLO, F., FONTANINI, G., PACIFICO, F., NORMANNO, N., BRANDT, R., PERSICO, M.G., SALOMON, D.S. and BIANCO, A.R., Inhibition of CRIPTO expression and tumorigenicity in human colon-cancer cells by anti-sense RNA and oligodeoxynucleotides. Oncogene. 9, 291-298 (1994).
11. FAN, Z., BASELGA, J., MASUI, H. and MENDELSOHN, J., Anti-tumor effect of anti-epidermal-growth-factor-receptor monoclonal antibodies plus cis-diamminodichloroplatinum on well-established A431 cell xenografts. Cancer Res., 53, 4637-4642 (1993).
12. HANCOCK, M.C., LANGTON, B., CHAN, T., TOY, P., MONAHAN, J.J., MISCHAK, R.P. and SHAWVER, L.K., A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminodichloroplatinum against human breast- and ovarian-tumor cell lines. Cancer Res., 51, 4575-4580 (1993).
13. KINOSHITA, N., MINSHULL, J. and KIRSCHNER, M.W., The identification of two novel ligands of the FGF receptor by a yeast screening method and their activity in Xenopus development. Cell, 83, 621-630 (1995).
14. KRONING, R., JONES, J.A., HOM, D.K., CHUANG, C.C., SANGA, R., Los, G., HOWELL. S.B. and CHRISTEN, R.D., Enhancement of drug sensitivity of human malignancies by epidermal growth factor. Brit. J. Cancer, 72, 615-620 (1995).
15. LANGTON, B., XUAN, J.-A., BRINK, J.R. and SALOMON, D.S., Development of resistance to cisplatin is associated with decreased expression of the gp185c-erbB-2 protein and alterations in growth properties and responses to therapy in an osarian-tumor cell line. Cell Growth Diff., 5, 1367-1372 1994).
16. MASSAGUÉ. J., Transforming growth factor ́. J. biol. Chem., 265, 21393-21396 (1990).
17. NORMXNNO, N., BIANCO, C., DAMIANO, V. DE ANGELIS, E., SELVAM, M.P., GRASSI, M., MAGLILO, G., TORTORA, G., BIANCO, A.R., MENDELSOHN, J., SALOMON, D.S. and CIARDIELLO, K. Growth inhibition of human colon-carcinoma cells by combinations of anti-epidermal-Growth-factor-related growth factor anti-sense oligonucleotides. Clin. Cancer Res., 2, 601-609 (1996).
18. NORMANNO, N., SELVAM, M.P., BIANCO, C., DAMIANO, V., DE ANGELIS, E., GRASSI, M., MAGLIULO, G., TORTORA, G., SALOMON, D.S. and CIARDIKLLO, F., Amphiregulin anti-sense oligodeoxynucleotides inhibit growth and transformation of a human colon-carcinoma cell line. Int. J. Cancer. 62, 762-766 (1995).
19. PIETRAS, R.J., FENDLY, B.M., CHAZIN, V.R., PEGRAM, M.D., HOWELL, S.B. and SLAMON, D.J., Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast- and ovarian-cancer cells. Oncogene, 9, 1829-1838 (1994).
20. SAEKI, T., CHEN-FENG, Q., JOHNSON, G.R., GULLICK, W., TAMARA. E., NORMANNO, N., CIARDIELLO, F., KENNEY, N., STROMBERG, K. and SALOMON, D.S., Differential immunoistochemical localization of amphiregulin and cripto in human normal colon and colorectal tumors. Cancer Res., 52, 3467-3473 (1992).
21. SAEKI, T., SALOMON, D.S., JOHNSON, G,R., GULLICK, W.J., MANDAI, K., YAMAGAMI, K., MORIWAKI, S., TANADA, M., TAKASHIMA,. S. and TAHARA, E., Association of epidermal-growth-factor-related peptides and type-I-receptor tyrosine-kinase receptors with prognosis of human colorectal carcinomas. Jap. J. clin. Oncol., 25, 240-249 (1995).
22. SALOMON, D.S., BRANDT, R., CIARDIELLO, F. and NORMANNO, N., Epidermal-growth-factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol., 19, 183-232 (1995).
23. SALOMON, D.S., DICKSON, R.B., NORMANNO, N., SAEKI, T., KIM, N., KENNEY, N. and CIARDIELLO, F., Interaction of oncogenes and growth factors in colon and breast cancer. In: D.A. Spandidos (ed.). Current perspectives on molecular and cellular oncology, pp. 211-261, JAI Press, London (1992).
24. SHOYAB, M., PLOWMAN. G.D., MCDONALD, V.L., BRADLEY, J.G. and TODARO, G.J., Structure and function of human amphiregulin: a member of the epidermal-growth-factor family. Science, 243, 1074-1076 (1989).
25. SKORSKI, T., NIEBOROWSKA-SKORSKA, M., BARLETTA, C., MALAGUARNERA, L., SZCZYLIK, C., CHEN, ST., LANGE, B. and CALABRETTA, B., Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl anti-sense oligodeoxynucleotides combined with mafosfamide. J. clin. Invest., 92, 194-202 (1993).